| P50 | author | Ewan Plant | Q30511389 |
| P2093 | author name string | Xing Li | |
| | Olga Zoueva | |
| | Zhiping Ye | |
| | Michael J Cooper | |
| | Hang Xie | |
| | Martina Kosikova | |
| | Meng-Jung Chiang | |
| | Angelia A Cost | |
| | Blake A Hatcher | |
| | Lucy J Fredell | |
| P2860 | cites work | Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years | Q79635571 |
| | Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly | Q21560857 |
| | The evolution of human influenza viruses | Q24522380 |
| | Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses | Q27644544 |
| | A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen | Q27701889 |
| | Influenza-related mortality trends in Japanese and American seniors: evidence for the indirect mortality benefits of vaccinating schoolchildren | Q28743079 |
| | Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans | Q30354893 |
| | Pre-existing cross-reactive antibodies to avian influenza H5N1 and 2009 pandemic H1N1 in US military personnel | Q30356053 |
| | Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses. | Q30356476 |
| | Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. | Q30361230 |
| | Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic | Q30363471 |
| | Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection | Q30366832 |
| | Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination. | Q30368005 |
| | Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers. | Q30369530 |
| | Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine. | Q30384943 |
| | The priming effect of previous natural pandemic H1N1 infection on the immunogenicity to subsequent 2010-2011 influenza vaccination in children: a prospective cohort study | Q30392073 |
| | Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial. | Q30392551 |
| | Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. | Q30392786 |
| | Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis | Q30408691 |
| | Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender | Q30411189 |
| | Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals | Q30420571 |
| | A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine | Q30422975 |
| | Profiling of humoral response to influenza A(H1N1)pdm09 infection and vaccination measured by a protein microarray in persons with and without history of seasonal vaccination | Q30426571 |
| | Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model | Q33538308 |
| | Significant cross reactive antibodies to influenza virus in adults and children during a period of marked antigenic drift | Q33938415 |
| | Integrating influenza antigenic dynamics with molecular evolution | Q34039764 |
| | Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants | Q34279996 |
| | Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons | Q34393525 |
| | Antibody landscapes after influenza virus infection or vaccination. | Q34580640 |
| | The effect of age and recent influenza vaccination history on the immunogenicity and efficacy of 2009-10 seasonal trivalent inactivated influenza vaccination in children | Q34648699 |
| | Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review | Q34778408 |
| | Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease | Q35837747 |
| | Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination | Q36306922 |
| | Quantifying Protection Against Influenza Virus Infection Measured by Hemagglutination-inhibition Assays in Vaccine Trials | Q36317045 |
| | Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans | Q36496580 |
| | Variable efficacy of repeated annual influenza vaccination | Q36705674 |
| | Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies | Q36911722 |
| | Influenza vaccine effectiveness in the community and the household | Q36956943 |
| | Incidence of Medically Attended Respiratory Syncytial Virus and Influenza Illnesses in Children 6-59 Months Old During Four Seasons | Q37091628 |
| | Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial | Q37107424 |
| | Kinetics and longevity of antibody response to influenza A H5N1 virus infection in humans | Q37256096 |
| | Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination | Q37320688 |
| | Age- and sex-related risk factors for influenza-associated mortality in the United States between 1997-2007. | Q37414685 |
| | Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11. | Q37568436 |
| | Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older | Q38380921 |
| | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 |
| | Influenza Vaccine Effectiveness in Preventing Influenza Illness Among Children During School-based Outbreaks in the 2014-2015 Season in Beijing, China | Q39142665 |
| | Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness | Q39429254 |
| | Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014. | Q40644474 |
| | The hemagglutination inhibition antibody responses to an inactivated influenza vaccine among healthy adults: with special reference to the prevaccination antibody and its interaction with age. | Q40660338 |
| | Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6-59 months, October 2011-September 2012: A matched test-negative case-control study in Suzhou, China | Q40740131 |
| | Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons | Q41053454 |
| | Trivalent inactivated seasonal influenza vaccine effectiveness for the prevention of laboratory-confirmed influenza in a Scottish population 2000 to 2009. | Q41289347 |
| | Impact of influenza vaccination on respiratory illness rates in children attending private boarding schools in England, 2013-2014: a cohort study | Q41332218 |
| | The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses | Q42790878 |
| | Kinetics of the antibody response to seasonal influenza vaccination among the elderly | Q43171479 |
| | Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses | Q44211857 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5258 | |
| P577 | publication date | 2017-07-12 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza Strains | |
| P478 | volume | 7 | |